Inhibition of TROY promotes OPC differentiation and increases therapeutic efficacy of OPC graft for spinal cord injury

Stem Cells and Development

Volumn 23, Issue 17, 2014, Pages 2104-2118

  Sun, Liang ^a   Liu, Shengliang ^a   Sun, Qi ^a   Li, Zhuying ^b   Xu, Fengyan ^a   Hou, Chunmei ^a   Harada, Toshihide ^c   Chu, Ming ^d   Xu, Kun ^d   Feng, Xiaoling ^b   Duan, Yongshun ^d   Zhang, Yafang ^a   Wu, Shuliang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b University of Chinese Medicine   (China)

^c PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^d THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C; REGULATOR PROTEIN; RNA DIRECTED DNA POLYMERASE; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 19; UNCLASSIFIED DRUG; PROTEIN KINASE INHIBITOR; TNFRSF19 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL TRANSPLANTATION; COCULTURE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; INFANT; MOUSE; MYELIN SHEATH; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE FIBER REGENERATION; NEUROMODULATION; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMYELINIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; SPINAL GANGLION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; GENETICS; METABOLISM; MYELINATED NERVE; NEURAL STEM CELL; OLIGODENDROGLIA; PATHOLOGY; PHYSIOLOGY; SPINAL CORD; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENE KNOCKDOWN TECHNIQUES; MICE, INBRED C57BL; NERVE FIBERS, MYELINATED; NEURAL STEM CELLS; OLIGODENDROGLIA; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84906541052     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0563     Document Type: Article

References (52)

1. Nishiyama A, M Komitova, R Suzuki and X Zhu. (2009). Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 10:9-22.
2. Vigano F, W Mobius, M Gotz and L Dimou. (2013). Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain.Nat Neurosci 16:1370-1372.
3. Hughes EG, SH Kang, M Fukaya and DE Bergles. (2013). Oligodendrocyte progenitors balance growth with selfrepulsion to achieve homeostasis in the adult brain. Nat Neurosci 16:668-676.
4. Yu Y, Y Chen, B Kim, H Wang, C Zhao, X He, L Liu, W Liu, LM Wu, et al. (2013). Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell 152:248-261.
5. Waxman SG. (2006). Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat Rev Neurosci 7:932-941.
6. Courtine G, MB Bunge, JW Fawcett, RG Grossman, JH Kaas, R Lemon, I Maier, J Martin, RJ Nudo, et al. (2007). Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?. Nat Med 13:561-566.
7. Imai M, M Watanabe, K Suyama, T Osada, D Sakai, H Kawada, M Matsumae and J Mochida. (2008). Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model. J Neurosurg Spine 8:58-66.
8. Su Z, Y Yuan, J Chen, Y Zhu, Y Qiu, F Zhu, A Huang and C He. (2011). Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-alpha. J Neurotrauma 28:1089-1100.
9. Meijer DH, MF Kane, S Mehta, H Liu, E Harrington, CM Taylor, CD Stiles and DH Rowitch. (2012). Separated at birth?. The functional and molecular divergence of OLIG1 and OLIG2. Nat Rev Neurosci 13:819-831.
10. Wake H, PR Lee and RD Fields. (2011). Control of local protein synthesis and initial events in myelination by action potentials. Science 333:1647-1651.
11. Miron VE, A Boyd, JW Zhao, TJ Yuen, JM Ruckh, JL Shadrach, P van Wijngaarden, AJ Wagers, A Williams, RJ Franklin and C Ffrench-Constant. (2013). M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211-1218.
12. Furusho M, Y Kaga, A Ishii, JM Hebert and R Bansal. (2011). Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain. J Neurosci 31:5055-5066.
13. Chan JR, TA Watkins, JM Cosgaya, C Zhang, L Chen, LF Reichardt, EM Shooter and BA Barres. (2004). NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43:183-191.
14. Wang S, AD Sdrulla, G diSibio, G Bush, D Nofziger, C Hicks, G Weinmaster and BA Barres. (1998). Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21:63-75.
15. Michailov GV, MW Sereda, BG Brinkmann, TM Fischer, B Haug, C Birchmeier, L Role, C Lai, MH Schwab and KA Nave. (2004). Axonal neuregulin-1 regulates myelin sheath thickness. Science 304:700-703.
16. Liang X, NA Draghi and MD Resh. (2004). Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci 24:7140-7149.
17. Baron W, JC de Jonge, H de Vries and D Hoekstra. (1998). Regulation of oligodendrocyte differentiation: protein kinase C activation prevents differentiation of O2A progenitor cells toward oligodendrocytes. Glia 22: 121-129.
18. Heinrich M, M Gorath and C Richter-Landsberg. (1999). Neurotrophin-3 (NT-3) modulates early differentiation of oligodendrocytes in rat brain cortical cultures. Glia 28:244-255.
19. Baer AS, YA Syed, SU Kang, D Mitteregger, R Vig, C Ffrench-Constant, RJ Franklin, F Altmann, G Lubec and MR Kotter. (2009). Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 132:465-481.
20. Paez PM, DJ Fulton, V Spreur, V Handley and AT Campagnoni. (2010). Multiple kinase pathways regulate voltage-dependent Ca2 + influx and migration in oligodendrocyte precursor cells. J Neurosci 30:6422-6433.
21. Guo L, T Eviatar-Ribak and R Miskimins. (2010). Sp1 phosphorylation is involved in myelin basic protein gene transcription. J Neurosci Res 88:3233-3242.
22. Hisaoka T, Y Morikawa, T Kitamura and E Senba. (2003). Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain. Brain Res Dev Brain Res 143:105-109.
23. Hisaoka T, Y Morikawa, T Komori, T Sugiyama, T Kitamura and E Senba. (2006). Characterization of TROYexpressing cells in the developing and postnatal CNS: the possible role in neuronal and glial cell development. Eur J Neurosci 23:3149-3160.
24. Hisaoka T, Y Morikawa and E Senba. (2006). Characterization of TROY/TNFRSF19/TAJ-expressing cells in the adult mouse forebrain. Brain Res 1110:81-94.
25. Morikawa Y, T Hisaoka, T Kitamura and E Senba. (2008). TROY, a novel member of the tumor necrosis factor receptor superfamily in the central nervous system. Ann N Y Acad Sci 1126:A1-A10.
26. Park JB, G Yiu, S Kaneko, J Wang, J Chang, XL He, KC Garcia and Z He. (2005). A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 45: 345-351.
27. Shao Z, JL Browning, X Lee,ML Scott, S Shulga-Morskaya, N Allaire, G Thill, M Levesque, D Sah, et al. (2005). TAJ/ TROY, an orphan TNF receptor family member, binds Nogo- 66 receptor 1 and regulates axonal regeneration. Neuron 45: 353-359.
28. Kotter MR, WW Li, C Zhao and RJ Franklin. (2006). Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26: 328-332.
29. Chen Y, V Balasubramaniyan, J Peng, EC Hurlock, M Tallquist, J Li and QR Lu. (2007). Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc 2:1044-1051.
30. Deshmukh VA, V Tardif, CA Lyssiotis, CC Green, B Kerman, HJ Kim, K Padmanabhan, JG Swoboda, I Ahmad, et al. (2013). A regenerative approach to the treatment of multiple sclerosis. Nature 502:327-332.
31. Basso DM, MS Beattie and JC Bresnahan. (1996). Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244-256.
32. Nori S, Y Okada, A Yasuda, O Tsuji, Y Takahashi, Y Kobayashi, K Fujiyoshi, M Koike, Y Uchiyama, et al. (2011). Grafted human-induced pluripotent stem-cellderived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A 108:16825-16830.
33. Maybhate A, C Hu, FA Bazley, Q Yu, NV Thakor, CL Kerr and AH All. (2012). Potential long-term benefits of acute hypothermia after spinal cord injury: assessments with somatosensory-evoked potentials. Crit Care Med 40: 573-579.
34. Gao FB, J Apperly and M Raff. (1998). Cell-intrinsic timers and thyroid hormone regulate the probability of cellcycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev Biol 197:54-66.
35. Billon N, Y Tokumoto, D Forrest and M Raff. (2001). Role of thyroid hormone receptors in timing oligodendrocyte differentiation. Dev Biol 235:110-120.
36. Fernandez M, A Giuliani, S Pirondi, G D'Intino, L Giardino, L Aloe, R Levi-Montalcini and L Calza. (2004). Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci U S A 101:16363-16368.
37. Mi S, RH Miller, X Lee, ML Scott, S Shulag-Morskaya, Z Shao, J Chang, G Thill, M Levesque, et al. (2005). LINGO- 1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8:745-751.
38. Keirstead HS, G Nistor, G Bernal, M Totoiu, F Cloutier, K Sharp and O Steward. (2005). Human embryonic stem cellderived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4694-4705.
39. Powers BE, DL Sellers, EA Lovelett, W Cheung, SP Aalami, N Zapertov, DO Maris and PJ Horner. (2013). Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin. Proc Natl Acad Sci U S A 110:4075-4080.
40. Eby MT, A Jasmin, A Kumar, K Sharma and PM Chaudhary. (2000). TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell death. J Biol Chem 275:15336-15342.
41. Wang Y, X Li, L Wang, P Ding, Y Zhang, W Han and D Ma. (2004). An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci 117:1525-1532.
42. Satoh J, H Tabunoki, T Yamamura, K Arima and H Konno. (2007). TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol Appl Neurobiol 33:99-107.
43. Paulino VM, Z Yang, J Kloss, MJ Ennis, BA Armstrong, JC Loftus and NL Tran. (2010). TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling. Mol Cancer Res 8:1558-1567.
44. Jacobs VL, Y Liu and JA De Leo. (2012). Propentofylline targets TROY, a novel microglial signaling pathway. PLoS One 7:e37955.
45. Brandlin I, T Eiseler, R Salowsky and FJ Johannes. (2002). Protein kinase C(mu) regulation of the JNK pathway is triggered via phosphoinositide-dependent kinase 1 and protein kinase C(epsilon). J Biol Chem 277:45451-45457.
46. Lopez-Bergami P, H Habelhah, A Bhoumik, W Zhang, LH Wang and Z Ronai. (2005). RACK1 mediates activation of JNK by protein kinase C [corrected]. Mol Cell 19: 309-320.
47. Lopez-Bergami P and Z Ronai. (2008). Requirements for PKC-augmented JNK activation by MKK4/7. Int J Biochem Cell Biol 40:1055-1064.
48. All AH, FA Bazley, S Gupta, N Pashai, C Hu, A Pourmorteza and C Kerr. (2012). Human embryonic stem cellderived oligodendrocyte progenitors aid in functional recovery of sensory pathways following contusive spinal cord injury. PLoS One 7:e47645.
49. Yang N, JB Zuchero, H Ahlenius, S Marro, YH Ng, T Vierbuchen, JS Hawkins, R Geissler, BA Barres and M Wernig. (2013). Generation of oligodendroglial cells by direct lineage conversion. Nat Biotechnol 31:434-439.
50. Hu BY, JP Weick, J Yu, LX Ma, XQ Zhang, JA Thomson and SC Zhang. (2010). Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 107:4335-4340.
51. Najm FJ, A Zaremba, AV Caprariello, S Nayak, EC Freundt, PC Scacheri, RH Miller and PJ Tesar. (2011). Rapid and robust generation of functional oligodendrocyte progenitor cells from epiblast stem cells. Nat Methods 8: 957-962.
52. Wang S, J Bates, X Li, S Schanz, D Chandler-Militello, C Levine, N Maherali, L Studer, K Hochedlinger, M Windrem and SA Goldman. (2013). Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12:252-264.